MAPK3 and neoplasm: We constructed a very unique plasmid that expressed Cre recombinase fused to an estrogen receptor (ERT2) under the control of a HIF-1-dependent 5HRE promoter, and established a system to tag HIF-1–positive hypoxic tumor cells with luciferase proteins in a tumor xenograft [6].